Investigating How Childhood Tumours and Congenital Disease Develop
This study is investigating how serious childhood conditions, such as tumours and congenital disorders (problems present from birth), develop. Every human starts as a single fertilised egg, which then grows and develops following instructions in our DNA. This research focuses on finding out exactly when and how mistakes in this DNA code happen, leading to these conditions. By comparing the DNA of affected children with their parents' DNA, scientists hope to pinpoint the very first changes that occur during development. Understanding these early changes could help improve our knowledge of how these diseases start, potentially leading to better ways to understand and support children affected in the future.
At a glance
What is this study about?
When a baby starts to grow inside the womb, it begins as a single cell. This cell divides and multiplies, following a precise set of instructions contained in its DNA – think of DNA as the body's instruction manual. This amazing process builds a complete human being. However, sometimes, slight errors or 'typos' can creep into these DNA instructions during development. When these errors happen, they can disrupt the normal process of growth and lead to conditions like childhood tumours or congenital diseases, which are problems a child is born with.
This research aims to understand these DNA errors much better. Scientists want to identify exactly which DNA changes are responsible for these conditions and, crucially, when these changes first appear. They believe some errors might happen very early, even before a baby is born. By carefully analysing the DNA from children with these conditions and comparing it to their parents' DNA, the researchers hope to piece together the 'life story' of how these conditions begin at a very fundamental level.
The ultimate goal is to gain a clearer picture of the very first steps that lead to these conditions. This deeper understanding is crucial for all future research into childhood tumours and congenital disorders, as it could eventually help in finding new ways to diagnose, treat, or even prevent them. It's a foundational study that adds vital knowledge to our understanding of human development and disease.
Key takeaways
- This study investigates why childhood tumours and congenital diseases develop.
- It focuses on understanding early DNA changes in affected children.
- Participation involves using existing, 'leftover' tissue samples; no new procedures.
- There are no direct risks or personal benefits for participants, but it greatly aids research.
- It helps us learn how these conditions start, potentially improving future care.
Who may be eligible?
This study is looking for participants of any age, including children, who have been diagnosed with a childhood tumour or a congenital disease (a condition they were born with). Family members of someone with these conditions may also be able to take part.
To be included, there needs to be enough 'leftover' tissue available from previous medical procedures that is no longer needed for their diagnosis or treatment. This ensures no new procedures are required solely for the study.
Before anyone takes part, if they are a child, they will be asked if they are happy to participate (this is called 'assent'). Their parent or guardian will also need to give their full consent. Researchers will explain everything clearly, so everyone involved understands what taking part means.
- Do you or your child have a childhood tumour or a condition present since birth?
- Is there any leftover tissue from past medical procedures that is no longer needed?
- If a child is involved, are they happy to take part and does a parent/guardian agree?
- Are you able to provide consent for your or your child's data and samples to be used?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you or your child are eligible and choose to take part, the main involvement will be allowing researchers to use 'leftover' tissue samples. These are samples that were already collected for diagnostic tests or treatments and are no longer needed by the hospital. No new procedures will be performed simply for this study, meaning no extra visits, assessments, medication, or follow-up appointments are required for study purposes. This study focuses on analysing existing samples, so there is no fixed 'duration' of participation for individuals beyond the initial consent process.
Potential risks and benefits
Locations (1)
- Wellcome Sanger InstituteCambridge, United Kingdom
Common questions
What is 'congenital disease'?
'Congenital disease' means a health condition or problem that a child is born with, rather than one they develop later in life.
Will taking part involve any extra tests or hospital visits?
No, taking part in this study will not involve any extra tests, procedures, or hospital visits for you or your child. The researchers will only use samples that have already been collected for medical reasons.
What does 'DNA errors' mean?
DNA errors, or 'mutations', are like tiny typos in the body's instruction manual (DNA). These typos can sometimes change how the body develops or functions.
How will this study help children?
By understanding the very first steps of how these conditions develop, this study aims to build a stronger foundation of knowledge. This could eventually lead to new ways to diagnose, treat, or even prevent childhood tumours and congenital diseases in the future.
Will my or my child's personal details be kept private?
Yes, all personal information and samples will be handled with strict confidentiality and in line with privacy regulations. Your identity will be protected.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.